Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Breast Cancer × copanlisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 14 Lymphoma, Large B-Cell, Diffuse 8 Neoplasm Metastasis 7 Breast Neoplasms 6 Neoplasms 5 Lymphoma, Follicular 5 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Hodgkin Disease 3 Endometrial Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Lymphoma, B-Cell, Marginal Zone 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Spinocerebellar Degenerations 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Primary Myelofibrosis 1

Interventions

pyrotinib 3 Trastuzumab 3 Vinorelbine 2 copanlisib 1 Lapatinib 1 Docetaxel 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02705859 2025-01-09

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡